Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Schade

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Diabetes Technology & Therapeutics|July 28, 2001
Repaglinide dose response? A clinician's viewpointD S Schade
The Medical Clinics of North America|November 1, 1988
Surgery and diabetesD S Schade
Diabetes/Metabolism Reviews|June 1, 1988
Brittle diabetes: strategies, diagnosis, and treatmentD S Schade
Ciba Foundation Symposium|January 1, 1982
The role of catecholamines in metabolic acidosisD S Schade
Academic Medicine : Journal of the Association of American Medical Colleges|June 27, 1998
General Clinical Research Center Scholars ProgramD S Schade
Diabetologia|October 1, 1981
Current status of portable insulin infusion devices. Satellite workshop on portable insulin infusion devices. (Preceding the XVth annual meeting of the European Society for Clinical Investigation) 18-19 March 1981, Basel, SwitzerlandU Keller, D S Schade
JAMA|July 7, 1975
Letter: Hypomagnessemia as a cause of persistent hypokalemiaS Webb, D S Schade
Endocrinology and Metabolism Clinics of North America|October 6, 1997
InsulinsM R Burge, D S Schade
The Journal of Clinical Endocrinology and Metabolism|January 1, 1980
The temporal relationship between endogenously secreted stress hormones and metabolic decompensation in diabetic manD S Schade, R P Eaton
Clinical and Experimental Pharmacology & Physiology|July 1, 1981
The ketotic ratio (KB/NEFA) in manD S Schade, R P Eaton
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Diabetes Technology & Therapeutics|July 28, 2001
Repaglinide dose response? A clinician's viewpointD S Schade
The Medical Clinics of North America|November 1, 1988
Surgery and diabetesD S Schade
Diabetes/Metabolism Reviews|June 1, 1988
Brittle diabetes: strategies, diagnosis, and treatmentD S Schade
Ciba Foundation Symposium|January 1, 1982
The role of catecholamines in metabolic acidosisD S Schade
Academic Medicine : Journal of the Association of American Medical Colleges|June 27, 1998
General Clinical Research Center Scholars ProgramD S Schade
Diabetologia|October 1, 1981
Current status of portable insulin infusion devices. Satellite workshop on portable insulin infusion devices. (Preceding the XVth annual meeting of the European Society for Clinical Investigation) 18-19 March 1981, Basel, SwitzerlandU Keller, D S Schade
JAMA|July 7, 1975
Letter: Hypomagnessemia as a cause of persistent hypokalemiaS Webb, D S Schade
Endocrinology and Metabolism Clinics of North America|October 6, 1997
InsulinsM R Burge, D S Schade
The Journal of Clinical Endocrinology and Metabolism|January 1, 1980
The temporal relationship between endogenously secreted stress hormones and metabolic decompensation in diabetic manD S Schade, R P Eaton
Clinical and Experimental Pharmacology & Physiology|July 1, 1981
The ketotic ratio (KB/NEFA) in manD S Schade, R P Eaton
Pageof 13